Researchers at Weill Cornell Medicine showed that starving a group of immune cells by inhibiting the activity of the enzyme Arginase-1 impairs the cells’ ability to induce an allergic response. The study, “Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation,” published in the journal…
Starving Innate Lymphoid Cells in Lung May Prevent Allergic Inflammation
It’s widely known that genetics may be a cause of the development of pulmonary fibrosis, but in the majority of the cases, the cause is unknown — a condition known as idiopathic pulmonary fibrosis. Each patient tends to have an individualized experience with the disease, which can progress faster or…
In this video from Baylor Scott & White Health, watch David P. Mason, M.D., chief of thoracic surgery and lung transplantation, discuss what lung transplantation is, and how it can both extend and improve pulmonary fibrosis and other lung diseases patients’ life. Learn more about…
Analysis of pooled data from three international, randomized, and placebo-controlled clinical trails — the Phase 2 TOMORROW trial and two Phase 3 INPULSIS trials — showed that nintedanib (Ofev) is an efficient and safe drug for the treatment of patients with idiopathic pulmonary fibrosis (IPF). The study, “Nintedanib…
Pulmonary Fibrosis Foundation shares a lot of tips on its website about how to deal with your pulmonary fibrosis. One of the things it wants to remind you is to be aware of how and where you search for information about your disease on the internet…
https://www.youtube.com/watch?v=JjH89WbO9js Baylor Scott & White Health shared this video in 2015, where they discussed if and when a person is too old to have a lung transplant. The video features the story of …
In this video from LabTV, shared in 2015, meet Preethi Vijayaraj, “a graduate student in the Gomperts Lab at UCLA”, who is focusing her research into finding a treatment for pulmonary fibrosis and other lung diseases. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA…
LabTV shared this video in late 2015, where you can meet Abdo Durra- a research assistant in the Gomperts Lab at UCLA. Durra wants to understand and treat lung diseases, his main purpose being to develop a research model for IPF. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA…
Researchers discovered that mice exposed to bleomycin — a common pulmonary fibrosis model — displayed more intense fibrotic activity if they lacked the signaling factor PTEN. The findings suggest that exploring the signaling pathway involving PTEN might offer new insights into disease mechanisms, and aid the search for new treatment…
1. 6 Non-Pharmacological Pulmonary Fibrosis Treatments According to PulmonaryFibrosis.org, there are several types of treatment options to help you with your pulmonary fibrosis. In this article, we’re focusing on bringing you non-pharmacological pulmonary fibrosis treatments. Read more about it: https://bit.ly/1SgrR74 2. …
